{
  "meta": {
    "title": "Post_Transcriptional_Modifications",
    "url": "https://brainandscalpel.vercel.app/post-transcriptional-modifications-1d442628.html",
    "scrapedAt": "2025-11-29T18:23:28.635Z"
  },
  "questions": [
    {
      "id": 9452,
      "choices": [
        {
          "id": 37775,
          "text": "<p><span style=\"font-size:12.0pt;\">7-methylguanosine capping at 5’ end</span></p>"
        },
        {
          "id": 37776,
          "text": "<p><span style=\"font-size:12.0pt;\">poly-A tail at 3’ end</span></p>"
        },
        {
          "id": 37777,
          "text": "<p><span style=\"font-size:12.0pt;\">Splicing</span></p>"
        },
        {
          "id": 37778,
          "text": "<p><span style=\"font-size:12.0pt;\">Gamma carboxylation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Among the options listed below, which one is not involved in the post-transcriptional processing of the primary mRNA transcript?</span></p>",
      "unique_key": "Q4463102",
      "question_audio": null,
      "question_video": null,
      "map_id": 30188,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D) Gamma carboxylation</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Gamma carboxylation</strong> is a <strong>post-translational modification</strong> that occurs in <strong>proteins</strong>, particularly in the <strong>synthesis of clotting factors,</strong> where it's crucial for <strong>calcium binding</strong>. It is <strong>not a modification</strong> that occurs during the <strong>post-transcriptional processing of mRNA.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. 7-methylguanosine capping at 5’ end:</strong> This is a <strong>modification </strong>that occurs <strong>shortly after the initiation of transcription</strong> and is crucial for mRNA stability and ribosome recognition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Poly-A tail at 3’ end:</strong> &nbsp;The addition of a <strong>poly-A tail </strong>is another key <strong>post-transcriptional modification</strong> that <strong>increases mRNA stability</strong> and aids in its export from the nucleus.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Splicing:</strong> Splicing involves the <strong>removal of introns</strong> and <strong>joining of exons</strong> to form a continuous coding sequence in mRNA.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Post-transcriptional modifications:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">7-methylguanosine capping at 5’ end</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Addition of a poly-A tail at 3’ end</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Removal of introns and joining of Exons called Splicing</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Methylations</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Alternative RNA Processing</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Post–translational Modifications</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Covalent modifications of aminoacyl residues</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Gamma carboxylation</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hydroxylation</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Methylation</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Glycosylation</span></p></li><li><span style=\"font-size:12.0pt;\">Zymogen activation.</span></li></ol>",
      "correct_choice_id": 37778,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9466,
      "choices": [
        {
          "id": 37831,
          "text": "<p><span style=\"font-size:12.0pt;\">RNA splicing</span></p>"
        },
        {
          "id": 37832,
          "text": "<p><span style=\"font-size:12.0pt;\">Allelic exclusion</span></p>"
        },
        {
          "id": 37833,
          "text": "<p><span style=\"font-size:12.0pt;\">Deamination of cytidine to uridine</span></p>"
        },
        {
          "id": 37834,
          "text": "<p><span style=\"font-size:12.0pt;\">Upstream repression</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">When discussing the differences between Apo-B48 and Apo-B100 proteins, which are both derived from the same ApoB gene but expressed differently in the intestine and liver, respectively, it's crucial to understand the molecular mechanism responsible for their diversity. These proteins are vital for lipid metabolism, with Apo-B48 being involved in chylomicron formation and Apo-B100 in VLDL and LDL. What process leads to the production of these distinct proteins from the same mRNA transcript?</span></p>",
      "unique_key": "Q7601025",
      "question_audio": null,
      "question_video": null,
      "map_id": 30190,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C) Deamination of Cytidine to Uridine</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>mRNA editing</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture9_kPLWTYS.jpg\" alt=\"\" width=\"400\" height=\"496\"></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the <strong>liver</strong>, the <strong>single apo-B gene</strong> is <strong>transcribed into an mRNA </strong>which <strong>leads to the synthesis of a 100-kDa protein</strong>, <strong>apo-B100.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the <strong>intestine</strong>, the <strong>same gene directs the synthesis</strong> of the <strong>primary transcript</strong> →cytidine deaminase converts a CAA codon in the mRNA to UAA at a single specific site.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Rather than <strong>encoding glutamine,</strong> this <strong>codon acts as a termination signal </strong>and a <strong>48-kDa protein</strong> (apoB48) is the result.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. RNA splicing:</strong> While <strong>RNA splicing</strong> is a <strong>common mechanism</strong> to <strong>generate protein diversity </strong>by removing introns from the pre-mRNA, it is not the process responsible for the difference between Apo-B48 and Apo-B100. These proteins result from the same gene and mRNA transcript but differ due to a specific editing event.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Allelic exclusion:</strong> This process, where <strong>only one allele of a gene is expressed</strong> while the <strong>other is silenced</strong>, is not related to the production of Apo-B48 and Apo-B100. These proteins come from the same mRNA transcript and gene but are differentially processed in different tissues.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Upstream repression:</strong> This refers to a <strong>regulatory mechanism</strong> where <strong>gene expression is inhibited by factors binding to regions upstream of the gene</strong>. This mechanism does not explain the production of two different proteins from the same mRNA transcript as seen with Apo-B48 and Apo-B100.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The <strong>difference between Apo-B48</strong> and <strong>Apo-B100 arises from the editing</strong> of the <strong>ApoB mRNA </strong>through the <strong>deamination of a specific cytidine</strong> to <strong>uridine in the intestinal cells</strong>. This conversion creates a stop codon in the mRNA, leading to the production of the shorter Apo-B48 protein in the intestine. In contrast, the liver cells do not perform this editing, resulting in the full-length Apo-B100 protein.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Harper 30/e page 393</strong></span></p>",
      "correct_choice_id": 37833,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9411,
      "choices": [
        {
          "id": 37611,
          "text": "<p><span style=\"font-size:12.0pt;\">mRNA editing</span></p>"
        },
        {
          "id": 37612,
          "text": "<p><span style=\"font-size:12.0pt;\">Alternate splicing</span></p>"
        },
        {
          "id": 37613,
          "text": "<p><span style=\"font-size:12.0pt;\">Translation of m RNA</span></p>"
        },
        {
          "id": 37614,
          "text": "<p><span style=\"font-size:12.0pt;\">RNA interference&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What does this diagram best illustrate about the regulation of gene expression in eukaryotic cells?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture3_hRzCPwf.jpg\" alt=\"\" width=\"400\" height=\"187\"></strong></span></p>",
      "unique_key": "Q7972539",
      "question_audio": null,
      "question_video": null,
      "map_id": 30183,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) Alternate splicing</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\"><span style=\"font-size:11pt;\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Eukaryotic mRNA </strong>undergoes <strong>several modifications </strong>such as <strong>5' Capping, 3’ polyadenylation </strong>and <strong>splicing </strong>before it is exported from the nucleus to the cytoplasm protein synthesis.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Tissue-specific protein isoforms </strong>can result from the <strong>same pre -mRNA </strong>through <strong>differential co-transcriptional processing</strong>, particularly the <strong>use of alternative splice sites</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">E.g.: Tropomyosin (TM) regulates the functions of actin in both muscle and nonmuscle cells. Its pre-mRNA undergoes tissue-specific differential splicing resulting in different TM isoforms.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. mRNA editing:</strong> It is a <strong>post-transcriptional modification</strong> of <strong>mRNA,</strong> which is seen in apolipoprotein (apo) B of chylomicrons and VLDL.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Translation of mRNA:</strong> Is the <strong>mechanism of regulation</strong> of <strong>translation</strong> by phosphorylation of the eukaryotic translation initiation factor, eIF-2.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. RNA interference: </strong>It is a <strong>mechanism of gene silencing </strong>either by repression of translation or increased degradation causing decreased expression of mRNA and it plays an important role in cell proliferation, differentiation, and apoptosis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Alternate splicing</strong>, a process by which <strong>different combinations of exons </strong>are <strong>joined </strong>(or spliced) <strong>together </strong>to <strong>generate multiple distinct mRNA transcripts </strong>from a <strong>single gene</strong>. This results in the <strong>production of different protein isoforms </strong>from the <strong>same DNA sequence</strong>, increasing the diversity of proteins that a single gene can produce.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Lippincott 7/e: P 457</strong></span></p>",
      "correct_choice_id": 37612,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7660,
      "choices": [
        {
          "id": 30608,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asparagine</span></span></span></p>"
        },
        {
          "id": 30609,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucosamine</span></span></span></p>"
        },
        {
          "id": 30610,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serine</span></span></span></p>"
        },
        {
          "id": 30611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cysteine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which amino acid can have an O-glycosylation linkage in an oligosaccharide molecule?<strong> </strong></span></span></span></p>",
      "unique_key": "Q4674585",
      "question_audio": null,
      "question_video": null,
      "map_id": 30187,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Serine</strong> can undergo<strong> O-glycosylation,</strong> where the <strong>hydroxyl (-OH)</strong> group of serine serves as the <strong>attachment site for the carbohydrate</strong> <strong>moiety.</strong> This<strong> type of glycosylation</strong> is common in the<strong> Golgi apparatus of eukaryotic cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Asparagine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - Typically involved in <strong>N-glycosylation</strong>, not O-glycosylation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Glucosamine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - A <strong>monosaccharid</strong>e,<strong> not an amino acid</strong>, involved in the construction of <strong>glycoproteins and glycolipids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Cysteine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- Contains a <strong>thiol (-SH) group, </strong>which is <strong>not </strong>a common site for <strong>glycosylation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Major Classes of Glycoproteins</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">O-linked Glycoprotein</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>O-glycosidic linkage</strong> between<strong> hydroxyl side chain </strong>of <strong>serine or threonine </strong>and <strong>N-acetyl galactosamine </strong>is present</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">N-linked Glycoprotein</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>N-glycosidic linkage </strong>between amide <strong>nitrogen of asparagine</strong> and <strong>N&ndash;acetyl glucosamine</strong> is present.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycosylphosphatidylinositol anchored (GPI-anchored, or GPI-linked) glycoproteins</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Third major class of Glycoproteins,</strong> which <strong>link several proteins to Plasma membrane.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linked to the <strong>carboxyl terminal amino acid </strong>of a protein via a<strong> phosphoryl ethanolamine </strong>moiety <strong>joined</strong> to an <strong>oligosaccharide (glycan), </strong>which in turn is<strong> linked</strong> via <strong>glucosamine to phosphatidylinositol (PI).</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 573.</span></span></strong></p>",
      "correct_choice_id": 30610,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9435,
      "choices": [
        {
          "id": 37707,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TATAAA</span></span></span></span></p>"
        },
        {
          "id": 37708,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CAAT </span></span></span></span></p>"
        },
        {
          "id": 37709,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CCA </span></span></span></span></p>"
        },
        {
          "id": 37710,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AAUAAA</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A geneticist is examining the impact of various mutations on mRNA processing in eukaryotic cells. They are particularly interested in a sequence that, if mutated, could disrupt the addition of the polyadenylation signal required for 3&#39;-end poly-A tail addition to the mRNA. Mutation in which of the following sequences would most likely affect this process?<strong> </strong></span></span></span></span></p>",
      "unique_key": "Q5761319",
      "question_audio": null,
      "question_video": null,
      "map_id": 30191,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) AAUAAA</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>endonuclease cleaves </strong>the <strong>messenger RNA </strong>just <strong>downstream to this polyadenylation signal</strong>, thus creating a <strong>new 3&#39;-end</strong>.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To the <strong>new 3&#39;-end</strong>, the <strong>poly A polymerase</strong> adds the <strong>poly-A tail using ATP </strong>as the <strong>substrate </strong>in a <strong>template-independent process. </strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A &amp; B:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>CAAT</strong> and <strong>TATAAA</strong> are <strong>sequences seen in promoters for RNA polymerase II</strong>. They help in proper transcription initiation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>CCA</strong> is added to the <strong>3&#39;-end of transfer RNA </strong>by <strong>nucleotidyl transferase</strong>. It is an amino acid attachment site on tRNA.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>sequence AAUAAA </strong>is the <strong>polyadenylation signal sequence </strong>in <strong>eukaryotic mRNAs</strong>, located <strong>near the 3&#39; end of the pre-mRNA</strong>. A mutation in this signal could disrupt the polyadenylation process, potentially affecting mRNA stability and translation efficiency.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 409,419-420, Lippincott 7/e: p 430.</span></span></strong></span></span></p>",
      "correct_choice_id": 37710,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9417,
      "choices": [
        {
          "id": 37635,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">mRNA degradation</span></span></span></span></p>"
        },
        {
          "id": 37636,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post Transcriptional modification</span></span></span></span></p>"
        },
        {
          "id": 37637,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Protein degradation</span></span></span></span></p>"
        },
        {
          "id": 37638,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Protein sorting </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the primary function of the cell organelles marked as &quot;P bodies&quot; in the given image?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture5_iLpmM9t.jpg\" style=\"height:214px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q2008108",
      "question_audio": null,
      "question_video": null,
      "map_id": 30186,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) mRNA degradation</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P Bodies</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>mRNA </strong>that are <strong>non-translating form </strong>of <strong>ribonucleoprotein particles </strong>which <strong>accumulate in cytoplasmic organelle </strong>called as <strong>P bodies</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>P bodies </strong>are <strong>sites for mRNA decay </strong>and <strong>translation repression</strong>.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>P bodies check </strong>the <strong>mRNA quality control </strong>with the <strong>help of mRNA decapping enzymes</strong>, RNA helicases and RNA exonucleases.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A portion of mRNA driven mRNA modulation takes place in P bodies</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Post transcriptional modification </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">occurs in <strong>different cell organelles </strong>&ndash; RER, Golgi, endosomes, lysosomes, and secretory vesicles.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Protein degradation: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Extracellular particles </strong>or proteins are taken by <strong>endocytosis fused </strong>with <strong>lysosomes.</strong> Intracellular proteins are also broken down by lysosomes. Ubiquitin tagged proteins are immediately broken down inside the <strong>proteasomes </strong>of the cells.<strong> </strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Protein sorting:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>RER, SER </strong>and <strong>golgi apparatus </strong>are involved in this process.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>P bodies</strong>, or <strong>processing bodies</strong>, are <strong>cytoplasmic granules </strong>that are involved in <strong>mRNA degradation </strong>and the <strong>regulation of mRNA stability</strong>. They play a key role in the post-transcriptional regulation of gene expression by sequestering mRNAs from the translational machinery. These mRNAs can be stored for future translation, degraded, or processed in P bodies.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 425,426</span></span></strong></span></span></p>",
      "correct_choice_id": 37635,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9441,
      "choices": [
        {
          "id": 37731,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exon 1 will be too long</span></span></span></span></p>"
        },
        {
          "id": 37732,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exon 1 will be too short</span></span></span></span></p>"
        },
        {
          "id": 37733,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exon 2 will be too long</span></span></span></span></p>"
        },
        {
          "id": 37734,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exon 2 will be too short</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 8-month-old male baby presented by its mother with severe anaemia and diagnosis of beta thalassemia was made. Gene analysis reveals one of his beta-globin genes has been mutated, which further creates a new splice acceptor site 17 nucleotides upstream of the normal splice acceptor site of the first intron. What is the most accurate prediction regarding the altered mRNA molecule? </span></span></span></span></p>",
      "unique_key": "Q3374762",
      "question_audio": null,
      "question_video": null,
      "map_id": 30182,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Exon 2 will be too long</span></span></strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to the <strong>mutation,</strong> additional <strong>splice acceptor site</strong> is <strong>created</strong> (the 3&#39;-end) <strong>upstream</strong> of the <strong>normal acceptor site</strong> of <strong>intron 1,</strong> the <strong>17 nucleotides</strong> that are usually <strong>found at the 3&#39;-end of the excised intron 1 lariat</strong> can <strong>remain</strong> as <strong>part of exon 2. </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, <strong>Exon 2 </strong>can have these <strong>extra 17 nucleotides </strong>at its <strong>5&#39;-end. </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to the <strong>presence of these extra nucleotides</strong> in the <strong>coding region </strong>of the <strong>mutant mRNA molecule,</strong> <strong>translation </strong>of the <strong>message from ribosome</strong> into a <strong>normal beta-globin protein molecule</strong> is prevented.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Exon 1 will be too long</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;This option is<strong> incorrect</strong> in the context of the mutation. The <strong>mutation is located at the splice acceptor site of the first intron</strong>, which affects splicing into exon 2, not exon 1.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Exon 1 will be too short:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is also <strong>incorrect</strong> based on the <strong>mutation&#39;s location.</strong> A new splice acceptor site within the first intron does not shorten exon 1; it would affect the downstream exon (exon 2) by including additional intron sequence.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Exon 2 will be too short</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;This option is <strong>incorrect </strong>because the <strong>mutation </strong>described would <strong>cause additional intronic sequence </strong>to be included in exon 2, making it longer, not shorter.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>genetic mutation </strong>introduces a <strong>new splice acceptor site </strong>in the <strong>first intron</strong>, which leads to the <strong>inclusion of additional intronic sequences </strong>in <strong>exon 2</strong>, making it longer than usual. This can result in an abnormal beta-globin protein, contributing to the pathology of beta-thalassemia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 7/e: P 427- 430</span></span></strong></span></span></p>",
      "correct_choice_id": 37733,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9443,
      "choices": [
        {
          "id": 37739,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Codominance</span></span></span></span></p>"
        },
        {
          "id": 37740,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gene switching</span></span></span></span></p>"
        },
        {
          "id": 37741,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allele exclusion</span></span></span></span></p>"
        },
        {
          "id": 37742,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Differential RNA processing</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the development of B cells, a critical genetic process allows these cells to produce a variety of immunoglobulin molecules, essential for the body&#39;s adaptive immune response. This flexibility is crucial for the immune system&#39;s ability to produce antibodies that can target an array of pathogens. Which process enables B cells to synthesize different types of immunoglobulin molecules?<strong> </strong></span></span></p>",
      "unique_key": "Q1810016",
      "question_audio": null,
      "question_video": null,
      "map_id": 30184,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Differential RNA processing</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alternative <strong>RNA Processing,</strong> includes an <strong>alternative Polyadenylation site </strong>in the <strong>&mu;Ig heavy chain primary transcript</strong>, leads to formation of two &mu; protein, <strong>&mu;m </strong>and <strong>&mu;s.</strong> </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One is membrane bound to <strong>B lymphocyte (&mu;m)</strong> and the other <strong>secreted (&mu;s).</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Codominance</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Codominance is a <strong>form of inheritance </strong>where <strong>different alleles are equally expressed</strong>, but it does not describe the process of immunoglobulin class synthesis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Gene switching:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &nbsp;Also known as <strong>class switch recombination</strong>, is a <strong>mechanism that changes</strong> the <strong>constant region of the heavy chain </strong>to <strong>produce different classes of immunoglobulins</strong>, it&#39;s related but the term might be confused with &quot;gene conversion&quot; which is not the same.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Allele exclusion:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a <strong>principle that ensures a B cell expresses </strong>only <strong>one type of heavy chain </strong>and <strong>one type of light chain,</strong> to ensure antigen specificity, not the generation of different types of immunoglobulins.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Differential RNA processing,</strong> also known as <strong>alternative RNA splicing,</strong> allows a <strong>single B cell </strong>to <strong>produce different classes </strong>of <strong>immunoglobulin molecules</strong>. After a B cell is activated, it can undergo class switching to produce different types of antibodies (e.g., switching from IgM to IgG production), but each of these classes can also result from differential splicing of the heavy chain RNA transcript.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e page 449</span></span></strong></span></span></p>",
      "correct_choice_id": 37742,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9454,
      "choices": [
        {
          "id": 37783,
          "text": "<p><span style=\"font-size:12.0pt;\">TRUE, as RNA editing is the mechanism that ensures introns are removed from pre-mRNA.</span></p>"
        },
        {
          "id": 37784,
          "text": "<p><span style=\"font-size:12.0pt;\">TRUE, because RNA editing and intron removal are synonymous terms in molecular biology.</span></p>"
        },
        {
          "id": 37785,
          "text": "<p><span style=\"font-size:12.0pt;\">FALSE, intron removal is accomplished through splicing, not RNA editing.</span></p>"
        },
        {
          "id": 37786,
          "text": "<p><span style=\"font-size:12.0pt;\">FALSE, RNA editing is primarily involved in modifying exon sequences and doesn't excise introns.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">When considering the process of mRNA maturation in eukaryotic cells, a critical step involves the removal of certain sequences before the mRNA can be translated into a protein. There's a statement that needs verification: \"Introns are excised by RNA editing.\" Is this statement accurate regarding the process by which introns are removed from pre-mRNA?</span></p>",
      "unique_key": "Q2107782",
      "question_audio": null,
      "question_video": null,
      "map_id": 30189,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. FALSE, intron removal is accomplished through splicing, not RNA editing.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The statement is <strong>false</strong> because <strong>introns are not removed by RNA editing</strong>, but by a distinct process known as <strong>RNA splicing</strong>.</span></p><p><span style=\"font-size:12.0pt;\"><strong>Splicing</strong> is the process in which <strong>non-coding introns are removed</strong> from the pre-mRNA transcript and <strong>coding exons are joined together</strong> to form a mature mRNA molecule ready for translation.</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The <strong>spliceosome</strong>, a large ribonucleoprotein complex made up of snRNA (small nuclear RNA) and proteins (snRNPs), is responsible for catalyzing splicing.</span></li><li><span style=\"font-size:12.0pt;\">This process is essential for <strong>gene expression in eukaryotes</strong>, ensuring that only exonic (coding) sequences are translated into protein.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">On the other hand, <strong>RNA editing</strong> is a post-transcriptional process that <strong>alters the nucleotide sequence</strong> of an RNA molecule <strong>after transcription</strong>. It may Substitute one nucleotide for another (e.g., <strong>C-to-U)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Example:</strong> The <strong>ApoB gene</strong> undergoes RNA editing in intestinal cells, where a <strong>C-to-U substitution</strong> introduces a stop codon, resulting in a shorter protein (ApoB48) compared to the full-length ApoB100 produced in the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, <strong>RNA editing modifies existing RNA sequences</strong> but <strong>does not remove introns</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Differentiate between <strong>RNA splicing</strong> and <strong>RNA editing</strong>:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Splicing</strong> removes introns and is required to create a translatable mRNA.</span></li><li><span style=\"font-size:12.0pt;\"><strong>RNA editing</strong> alters specific nucleotides in RNA but does <strong>not participate in intron removal</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ref: Harper 30/e page 367,411</span></p>",
      "correct_choice_id": 37785,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9446,
      "choices": [
        {
          "id": 37751,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, because snRNAs are part of the spliceosome complex that facilitates the removal of introns from pre-mRNA.</span></span></span></span></p>"
        },
        {
          "id": 37752,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False, because snRNAs are involved in the modification of rRNA, not in splicing.</span></span></span></span></p>"
        },
        {
          "id": 37753,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False, because splicing activity is solely the function of spliceosomal proteins, not snRNAs.</span></span></span></span></p>"
        },
        {
          "id": 37754,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, because snRNAs directly catalyze peptide bond formation in protein synthesis.</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A medical researcher studying gene expression, is reviewing the process of RNA splicing and the role of various components involved in this mechanism. They come across a question that tests their understanding of the components crucial for the splicing of pre-mRNA in eukaryotic cells. The question asks to identify the truthfulness of the statement regarding the function of snRNA in splicing activity. How would you assess the statement &quot;Splicing activity is a function of snRNA&quot;?</span></span></span></span></p>",
      "unique_key": "Q1263443",
      "question_audio": null,
      "question_video": null,
      "map_id": 30185,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) True, because snRNAs are part of the spliceosome complex that facilitates the removal of introns from pre-mRNA.</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>snRNAs</strong> (small nuclear RNAs) are <strong>integral to the spliceosome</strong>, the <strong>complex </strong>responsible for <strong>splicing pre-mRNA</strong> in <strong>eukaryotic cells.</strong> They <strong>form complexes</strong> with <strong>proteins known as snRNPs </strong>(small nuclear ribonucleoproteins), which <strong>recognize splice sites,</strong> participate in the <strong>catalysis of splicing reactions</strong>, and ensure the precise removal and joining of exons.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. False, because snRNAs are involved in the modification of rRNA, not in splicing:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>incorrect</strong> because the <strong>primary role of snRNAs is in splicing</strong>, not rRNA modification.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. False, because splicing activity is solely the function of spliceosomal proteins, not snRNAs</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is <strong>incorrect</strong> as <strong>snRNAs,</strong> <strong>complexed with proteins to form snRNPs</strong>, are essential for the splicing function of the spliceosome.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. True, because snRNAs directly catalyze peptide bond formation in protein synthesis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect because <strong>snRNAs are involved in splicing</strong>, not in the catalysis of peptide bonds during protein synthesis, which is a role of ribosomal RNA (rRNA) within the ribosome.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small Nuclear RNA (snRNA / snRNPs / snurps)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are <strong>uracil rich RNA </strong>which can <strong>act as enzymes</strong>, i.e., Ribozyme.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>U1, U2, U4, U5, U6</strong> involved in <strong>mRNA processing.</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">U7 in processing histone mRNA.<em> </em></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e page 367,411</span></span></strong></p>",
      "correct_choice_id": 37751,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}